Targeting Ephrin Receptor Tyrosine Kinase A2 with a Selective Aptamer for Glioblastoma Stem Cells

• Päätekijät: Alessandra Affinito (Tekijä), Cristina Quintavalle (Tekijä), Carla Lucia Esposito (Tekijä), Giuseppina Roscigno (Tekijä), Catello Giordano (Tekijä), Silvia Nuzzo (Tekijä), Lucia Ricci-Vitiani (Tekijä), Iolanda Scognamiglio (Tekijä), Zoran Minic (Tekijä), Roberto Pallini (Tekijä), Maxim V. Berezovski (Tekijä), Vittorio de Francisis (Tekijä), Gerolama Condorelli (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: Elsevier, 2020-06-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

Despite the benefits associated with radiotherapy and chemotherapy for glioblastoma (GBM) treatment, most patients experience a relapse following initial therapy. Recurrent or progressive GBM usually does not respond anymore to standard therapy, and this is associated with poor patient outcome. GBM...